In vitro and in vivo characterization of irreversible mutant-selective EGFR inhibitors that are wild-type sparing
不可逆突变选择性 EGFR 抑制剂(保留野生型)的体外和体内表征
期刊:Molecular Cancer Therapeutics
影响因子:5.3
doi:10.1158/1535-7163.MCT-13-0966
Robert Tjin Tham Sjin, Kwangho Lee, Annette O Walter, Aleksandr Dubrovskiy, Michael Sheets, Thia St Martin, Matthew T Labenski, Zhendong Zhu, Richland Tester, Russell Karp, Aravind Medikonda, Prasoon Chaturvedi, Yixuan Ren, Henry Haringsma, Jeff Etter, Mitch Raponi, Andrew D Simmons, Thomas C Hardin